Legend Biotech Corporation (FRA:9LB)
Germany flag Germany · Delayed Price · Currency is EUR
17.60
-0.50 (-2.76%)
At close: Aug 26, 2026

Legend Biotech Revenue

Legend Biotech had revenue of $387.50M USD in the quarter ending June 30, 2026, with 51.90% growth. This brings the company's revenue in the last twelve months to $1.27B, up 59.54% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth.

Revenue (ttm)
$1.27B
Revenue Growth
+59.54%
P/S Ratio
3.09
Revenue / Employee
$397.26K
Employees
3,200
Market Cap
3.44B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M15.02M25.04%
Dec 31, 201959.98M10.85M22.08%
Dec 31, 201849.13M25.54M108.24%
Dec 31, 201723.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Biotest GmbH & Co. KGaA648.90M
Novogenia AG54.30M
Paion AG14.81M
MagForce AG1.08M
Biomark Diagnostics37.15K
co.don AG22.00K
bioXXmed AG16.73K
2invest AG-1.64M
Revenue Rankings